A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients
- Submitting institution
-
University of Nottingham, The
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1329561
- Type
- D - Journal article
- DOI
-
10.1182/blood-2015-01-623447
- Title of journal
- Blood
- Article number
- -
- First page
- 3678
- Volume
- 125
- Issue
- 25
- ISSN
- 0006-4971
- Open access status
- Out of scope for open access requirements
- Month of publication
- April
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
12
- Research group(s)
-
C - Cancer and Stem Cell
- Citation count
- 134
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
